Mary Carter agreements and disclosure by drug manufacturers
Pickens, A.
Texas Medicine 74(10): 27-28
1978
ISSN/ISBN: 0040-4470 PMID: 715732 Document Number: 134585
Document emailed within 1 workday
Related Documents
Roffe, B.D.; Solomon, D.K. 1982: Manufacturers' warranty for drug products American Journal of Hospital Pharmacy 39(9): 1456-1457Ball, D.E.; Maidza, J.; Rusike, T.; Sharief, K.; Taderera, T.; Tangawarima, T. 2000: Drug use indicators at St Mary's Clinic Central African Journal of Medicine 46(2): 54-55
Rie Tsutsumi 2001: The nature of voluntary agreements in Japan functions of Environment and Pollution Control Agreements Journal of Cleaner Production 9(2): 145-153
Stevens, P. 1983: Nursing care study. Mary, Mary, quite contrary Nursing Times 79(22): 50-53
Fritsch, O.; Gueinzius, E. 1972: Application of economic agreements relating to drug products Pharmazeutische Praxis 9(Suppl 9): 199-120
Yang, Y-Yin.; Dong, Z.; Xia, Y-Peng. 2012: Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring Zhongguo Zhong Yao Za Zhi 37(21): 3329-3333
Parsons, J.T.; VanOra, J.; Missildine, W.; Purcell, D.W.; Gómez, C.A. 2004: Positive and negative consequences of HIV disclosure among seropositive injection drug users Aids Education and Prevention: Official Publication of the International Society for Aids Education 16(5): 459-475
Ford, K.; Wirawan, D.N.; Sumantera, G.M.; Sawitri, A.A.S.; Stahre, M. 2004: Voluntary HIV testing, disclosure, and stigma among injection drug users in Bali, Indonesia Aids Education and Prevention: Official Publication of the International Society for Aids Education 16(6): 487-498
Dima, A.L.; Stutterheim, S.E.; Lyimo, R.; de Bruin, M. 2014: Advancing methodology in the study of HIV status disclosure: the importance of considering disclosure target and intent Social Science and Medicine 108: 166-174
Kennedy, N.J.; Sanborn, J.S. 1992: Disclosure of tardive dyskinesia: effect of written policy on risk disclosure Psychopharmacology Bulletin 28(1): 93-100
Augusti, E.; Myhre, M.C. 2021: The Barriers and Facilitators to Abuse Disclosure and Psychosocial Support Needs in Children and Adolescents Around the time of Disclosure Child Care in Practice: 1-16
Ubesie, A.C.; Iloh, K.K.; Emodi, I.J.; Ibeziako, N.S.; Obumneme-Anyim, I.N.; Iloh, O.N.; Ayuk, A.C.; Anikene, C.J.; Enemuo, J.E. 2016: HIV status disclosure rate and reasons for non-disclosure among infected children and adolescents in Enugu, southeast Nigeria Sahara J: Journal of Social Aspects of Hiv/Aids Research Alliance 13(1): 136-141
Kouanda, S.; Yaméogo, W.M.E.; Berthé, A.; Bila, B.; Bocoum Yaya, F.K.; Somda, A.; Doulougou, B.; Sanou, M.J.; Sondo, B.; Msellati, P. 2012: Self-disclosure of a HIV-positive serostatus: factors favoring disclosure and consequences for persons living with HIV/AIDS in Burkina Faso Revue d'Epidemiologie et de Sante Publique 60(3): 221-228
Moses, S.; Tomlinson, M. 2013: The fluidity of disclosure: a longitudinal exploration of women's experience and understanding of HIV disclosure in the context of pregnancy and early motherhood Aids Care 25(6): 667-675
Grau, L.E.; White, E.; Niccolai, L.M.; Toussova, O.V.; Verevochkin, S.V.; Kozlov, A.P.; Heimer, R. 2011: HIV disclosure, condom use, and awareness of HIV infection among HIV-positive, heterosexual drug injectors in St. Petersburg, Russian Federation Aids and Behavior 15(1): 45-57
Kimura, T.; Funu, T. 1997: Carter-Robbins test Nihon Rinsho. Japanese Journal of Clinical Medicine 55(Suppl 2): 291-294
Kerr, A. 2016: 'The Carter efficiency programme is a world first' Journal of Wound Care 25(2): 59
2016: Carter proposes new nurse productivity measure NursingTimes 112(3-4): 3
Milne, D.W. 1980: Defeat of Carter's cost cap bill confirms Voluntary Effort success Modern Healthcare 10(1): 26
Piszczatowski, S. 2012: Geometrical aspects of growth plate modelling using Carter's and Stokes's approaches Acta of Bioengineering and Biomechanics 14(1): 93-106